Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
Status:
Unknown status
Trial end date:
2020-06-10
Target enrollment:
Participant gender:
Summary
This study will assess analgesia after robotic lung surgery. Subjects will be randomized to
receive wound infiltration and intercostal nerve block with either liposomal bupivacaine or
bupivacaine/epinephrine + dexamethasone. Liposomal bupivacaine is a newer local anesthetic
product and has not been compared to a combination of bupivacaine/epinephrine + dexamethasone
in the context of pain control after robotic lung surgery.